NRXP · Forms 3, 4, 5
Insider trades at NRX Pharmaceuticals, Inc.
No open-market insider buys or sells at NRX Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for NRX Pharmaceuticals, Inc. (NRXP) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for NRX Pharmaceuticals, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Joseph Michael Casper | Chief Operating Officer | Options or other derivatives | Form 4 | ||||
| Joseph Michael Casper | Chief Operating Officer | Became an insider (Form 3) | Form 3 | ||||
| Jonathan C Javitt | Chairman and Chief Scientist | Options or other derivatives | Form 4 | ||||
| Dennis McBride | Director | Options or other derivatives | Form 4 | ||||
| Chaim Hurvitz | Director | Options or other derivatives | Form 4 | ||||
| Patrick John Flynn | Director | Options or other derivatives | Form 4 | ||||
| B Group, Inc. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Michael S Abrams | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Jonathan C Javitt | Chairman and Chief Scientist | Buy | 40,000 | $1.17 | $47K | Form 4 | |
| Michael S Abrams | Chief Financial Officer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.